PLENAXIS Drug Patent Profile

✉ Email this page to a colleague

When do Plenaxis patents expire, and what generic alternatives are available?

Plenaxis is a drug marketed by Speciality European and is included in one NDA.

The generic ingredient in PLENAXIS is abarelix. Additional details are available on the abarelix profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for PLENAXIS?
What are the global sales for PLENAXIS?
What is Average Wholesale Price for PLENAXIS?

Summary for PLENAXIS

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	45
Clinical Trials:	3
Patent Applications:	4,209
DailyMed Link:	PLENAXIS at DailyMed

Drug patent expirations by year for PLENAXIS

Recent Clinical Trials for PLENAXIS

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
PRAECIS Pharmaceuticals Inc.	Phase 4
PRAECIS Pharmaceuticals Inc.	Phase 2
Speciality European Pharma Limited	Phase 3

See all PLENAXIS clinical trials

US Patents and Regulatory Information for PLENAXIS

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Speciality European	PLENAXIS	abarelix	INJECTABLE;INTRAMUSCULAR	021320-001	Nov 25, 2003		DISCN	No	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PLENAXIS

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Speciality European	PLENAXIS	abarelix	INJECTABLE;INTRAMUSCULAR	021320-001	Nov 25, 2003	⤷ Sign Up	⤷ Sign Up
Speciality European	PLENAXIS	abarelix	INJECTABLE;INTRAMUSCULAR	021320-001	Nov 25, 2003	⤷ Sign Up	⤷ Sign Up
Speciality European	PLENAXIS	abarelix	INJECTABLE;INTRAMUSCULAR	021320-001	Nov 25, 2003	⤷ Sign Up	⤷ Sign Up
Speciality European	PLENAXIS	abarelix	INJECTABLE;INTRAMUSCULAR	021320-001	Nov 25, 2003	⤷ Sign Up	⤷ Sign Up
Speciality European	PLENAXIS	abarelix	INJECTABLE;INTRAMUSCULAR	021320-001	Nov 25, 2003	⤷ Sign Up	⤷ Sign Up
Speciality European	PLENAXIS	abarelix	INJECTABLE;INTRAMUSCULAR	021320-001	Nov 25, 2003	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PLENAXIS

See the table below for patents covering PLENAXIS around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Algeria	2371	Formulations pharmaceutiques pour la distribution prolongée de médicaments.	⤷ Sign Up
Austria	432941		⤷ Sign Up
Austria	378059		⤷ Sign Up
Japan	2011105760	PHARMACEUTICAL FORMULATION CONTAINING WATER-INSOLUBLE COMPLEX FOR SUSTAINED DRUG DELIVERY	⤷ Sign Up
Argentina	010351	COMPOSICIONES FARMACÉUTICAS QUE COMPRENDEN UN COMPLEJO SoLIDO INSOLUBLE EN AGUA CUYA FORMACIoN ES MEDIADA AL MENOS EN PARTE POR INTERACCIONES IoNICAS DE UN ANÁLOGO LHRH Y UNA MACROMoLECULA PORTADORA, Y USO DE DICHA COMPOSICIoN PARA PREPARAR MEDICAMENTOS PARA TRATAR A UN SUJETO CON UNA AFECCIoN TRATA	⤷ Sign Up
Israel	180449		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for PLENAXIS

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0794961	CA 2011 00004	Denmark	⤷ Sign Up
0794961	SPC/GB11/006	United Kingdom	⤷ Sign Up	PRODUCT NAME: ABARELIX, OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT; REGISTERED: DE - 20050922; UK PL32828/001 20100917
0794961	11C0015	France	⤷ Sign Up	PRODUCT NAME: ABARELIX, EVENTUELLEMENT SOUS FORME DE SEL PHARMACEUTIQUEMENT ACCEPTABLE; REGISTRATION NO/DATE IN FRANCE: 69026150 DU 20101126; REGISTRATION NO/DATE AT EEC: 57890.00.00 DU 20050922
0794961	1190014-9	Sweden	⤷ Sign Up	PRODUCT NAME: ABARELIX
0794961	91225	Luxembourg	⤷ Sign Up	91225, EXPIRES: 20200922
0794961	91857	Luxembourg	⤷ Sign Up	91857, EXPIRES: 20200922
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for PLENAXIS

Recent Clinical Trials for PLENAXIS

Make Better Decisions: Try a trial or see plans & pricing